Home
>
National Drug Code (NDC)
>
Oratox
Oratox - 43742-0170-1 - (Fucus Vesiculosus, Lymph Node, Medula Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium)
Drug Information of Oratox
| Product NDC: | 43742-0170 |
| Proprietary Name: | Oratox |
| Non Proprietary Name: | Fucus Vesiculosus, Lymph Node, Medula Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium |
| Active Ingredient(s): | 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 8; 8; 8; 12; 12; 12; 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL & nbsp; Fucus Vesiculosus, Lymph Node, Medula Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Oratox
| Product NDC: | 43742-0170 |
| Labeler Name: | Deseret Biologicals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20121031 |
Package Information of Oratox
| Package NDC: | 43742-0170-1 |
| Package Description: | 30 mL in 1 BOTTLE, DROPPER (43742-0170-1) |
NDC Information of Oratox
| NDC Code | 43742-0170-1 |
| Proprietary Name | Oratox |
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-0170-1) |
| Product NDC | 43742-0170 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fucus Vesiculosus, Lymph Node, Medula Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20121031 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | Deseret Biologicals, Inc. |
| Substance Name | CALCIUM CHLORIDE; COPPER; EUGENOL; FORMALDEHYDE; FUCUS VESICULOSUS; GOLD; IODINE; LIDOCAINE; MERCURIUS SOLUBILIS; MOLYBDENUM; NICKEL; PALLADIUM; SELENIUM; SILVER; SODIUM CHLORIDE; SODIUM FLUORIDE; SUS SCROFA BONE MARROW; SUS SCROFA LYMPH; SUS SCROFA THYMUS; SUS SCROFA THYROID; TIN; TITANIUM; VANADIUM; ZINC |
| Strength Number | 12; 12; 12; 12; 3; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 12; 8; 8; 8; 8; 12; 12; 12; 12 |
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
| Pharmaceutical Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient] |
